Cancer

KSAT 12: People with cancer and COVID-19 twice as likely to die, new study says

June 3, 2020

Dr. Ruben Mesa, director of the Mays Cancer Center, was interviewed about the new study in The Lancet featuring data from the COVID-19 and Cancer Consortium. Mesa said the results from the nearly 1,000 patients showed the death rate of cancer patients who contract COVID-19 is about 13%, twice the rate of the general population. […]


Mays Cancer Center abstract selected as winner for AACI virtual meeting

June 2, 2020

This is the first abstract submitted by the Mays Cancer Center to be selected for presentation at the AACI meeting.


KOMO TV: Risk of death twice as high among cancer patients with COVID-19

June 1, 2020

Dr. Ruben Mesa, director of the Mays Cancer Center, is featured in this story about the results of a new COVID-19 and Cancer Consortium study published in The Lancet. According to the study, cancer patients who get COVID-19 have a 13% risk of dying, more than double the rate for all patients with COVID-19 combined. […]


eCancer.com: Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19)

June 1, 2020

Dr. Dimpy Shah, Mays Cancer Center, discusses the data into the clinical impact of COVID-19 on patients with cancer from the COVID-19 and Cancer Consortium (CCC19), presented at the 2020 ASCO virtual meeting. Read and watch the full story.


Science Codex.com: Cancer drugs cause large cells that resist treatment; scientist aims to stop it

May 29, 2020

A cancer therapy may shrink the tumor of a patient, and the patient may feel better. But unseen on a CT scan or MR image, some of the cells are undergoing ominous changes. Fueled by new genetic changes due to cancer therapy itself, these rogue cells are becoming very large with twice or quadruple the […]


Brinkwire.com: Cancer drugs cause large cells that resist treatment; scientist aims to stop it

May 29, 2020

A cancer therapy may shrink the tumor of a patient, and the patient may feel better. But unseen on a CT scan or MR image, some of the cells are undergoing ominous changes. Fueled by new genetic changes due to cancer therapy itself, these rogue cells are becoming very large with twice or quadruple the […]